Status:
COMPLETED
MoCA vs. MMS: Which Tool to Detect Cognitive Disorders in Oncogeriatric?
Lead Sponsor:
Centre Francois Baclesse
Collaborating Sponsors:
UCOG (Unite de coordination en Onco-Gériatrie)
Conditions:
Neoplasms
Eligibility:
All Genders
70+ years
Phase:
NA
Brief Summary
This study concerns elderly patients with cancer with onco-geriatric assessment. This study propose to associate the collection of the results with the Mini-Cog and the CODEX with the passing of the ...
Eligibility Criteria
Inclusion
- Patient aged over 70 years
- Patient with cancer (solid tumor or haemopathy) for whom a first line treatment is envisaged (whatever it is). Surgery and radiotherapy are allowed before entry into the study.
- Patient candidate for oncogeriatric assessment
- Patient agree to participate in the study
- Using the French language
Exclusion
- Primary central nervous system or cerebral metastasis
- Evolutionary psychiatric pathology known (e.g. schizophrenia)
- Severe Visual and / or Auditory Impairment
- Patients unable to respond to cognitive tests
- Patient (s) deprived of liberty, under guardianship or curatorship
- Refusal of participation
Key Trial Info
Start Date :
October 13 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 13 2023
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT03299855
Start Date
October 13 2017
End Date
October 13 2023
Last Update
October 18 2023
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre François Baclesse
Caen, France
2
CHU
Caen, France
3
CH
Cherbourg, France
4
Ch Compiegne
Compiègne, France